Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Vinorelbine and XR9576 to Treat Cancer [Phase 1]
Phase 1 study evaluating the combination of vinorelbine with XR9576, a P-glycoprotein inhibitor, in patients with breast, lung, and ovarian …
-
CLINICAL_TRIALS trial_result · 2008-01-03Clinical Trial Update: Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma [Phase 2]
Phase II trial evaluating a modified triple-doublet therapy in women with newly diagnosed Mullerian carcinomas (ovarian, fallopian tube, or …
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment [Phase 2]
Phase 2 study of Ovarex (Oregovomab) monoclonal antibody with front-line chemotherapy for ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma [Phase 2]
A Phase 2 multicenter trial evaluating intravenous OvaRex MAb-B43.13 as post-chemotherapy consolidation in ovarian cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Clinical Trial for Ovarian Cancer (OvaRex®) [Phase 3]
Phase 3 trial of OvaRex for ovarian cancer has been terminated (status TERMINATED) per clinicaltrials.gov; sponsor is Unither Pharmaceutical…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating the pharmacokinetics and safety of OvaRex MAb-B43.13 in ovarian epithelial carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating interferon gamma-1b plus chemotherapy for ovarian cancer and peritoneal cancer was terminated; the update discuss…
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial [Phase 2]
A randomized Phase II trial evaluating neoadjuvant chemotherapy with carboplatin and docetaxel in patients with advanced ovarian cancer.
-
FDA approval · 2007-10-11FDA Approved: HYCAMTIN — Original Application (Sandoz Inc)
FDA approved HYCAMTIN (topotecan) from Sandoz as the original application; the initial indications included treatment of relapsed small cell…
-
CLINICAL_TRIALS trial_result · 2007-10-04Clinical Trial Update: TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian [Phase 2]
Phase 2 trial evaluating TAX (docetaxel) with carboplatin or cisplatin as first-line post-surgery therapy for ovarian cancer; study status i…
-
CLINICAL_TRIALS research · 2007-09-21Clinical Trial Update: Hydralazine Valproate for Ovarian Cancer [Phase 3]
This update concerns a Phase 3 clinical trial evaluating a hydralazine and valproic acid combination for ovarian cancer.
-
CLINICAL_TRIALS research · 2007-09-11Clinical Trial Update: Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer [Phase 1]
This clinical trial update describes an early-phase study evaluating adjuvant whole abdominal IMRT for high-risk stage III ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2007-08-17Clinical Trial Update: Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating adding Herceptin to a carboplatin-paclitaxel regimen for ovarian cancer has been terminated.
-
CLINICAL_TRIALS research · 2007-08-13Clinical Trial Update: The Development of Human Immunologic Assays Specific to Folate Receptor Antigen [NA]
This entry reports on the development of human immunologic assays specific to the folate receptor antigen, in the context of ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2007-05-25Clinical Trial Update: A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment [Phase 4]
This Phase 4 study of arzoxifene (LY353381) completed, evaluating continuation of treatment in patients who had previously benefited. The st…
-
CLINICAL_TRIALS trial_result · 2007-05-17Clinical Trial Update: Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy [Phase 2]
Phase 2 trial of pemetrexed in patients with ovarian cancer or primary peritoneal cancer after platinum-based chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-15Clinical Trial Update: Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating motexafin gadolinium in combination with docetaxel for patients with advanced solid tumors; the study, including br…
-
CLINICAL_TRIALS research · 2007-04-24Clinical Trial Update: Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers [Phase 2]
A Phase 2 trial evaluating weekly carboplatin and docetaxel in platinum-sensitive relapsed ovarian, fallopian tube, or primary peritoneal ca…
-
CLINICAL_TRIALS research · 2007-04-20Clinical Trial Update: MRI in Staging Ovarian Cancer Using MRI Contrast Agent
A clinical trial update discusses using an MRI contrast agent to stage ovarian cancer in a study sponsored by the University of Aarhus. The …
-
CLINICAL_TRIALS research · 2007-03-02Clinical Trial Update: Blood Test for Ovarian Cancer Associated Antibodies (CAAb)
A clinical trial update concerning a blood test for ovarian cancer-associated antibodies (CAAb) sponsored by Lab Discoveries Ltd; the trial …
-
CLINICAL_TRIALS research · 2007-02-12Clinical Trial Update: Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. [NA]
Terminated clinical trial comparing Essiac (ESIAK) to placebo to improve quality of life in women transitioning with breast or ovarian cance…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. [Phase 3]
A Phase 3 randomized trial for platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS research · 2007-01-08Clinical Trial Update: Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
This clinical trial update describes a proteomic analysis of the HLA complex across multiple solid cancers, including breast, ovarian, color…
-
CLINICAL_TRIALS research · 2006-12-19Clinical Trial Update: The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients
An update describing the assessment of mesothelin antigen-specific immunologic assays in ovarian cancer patients.
-
CLINICAL_TRIALS trial_result · 2006-11-14Clinical Trial Update: Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer [Phase 3]
A Phase 3 trial comparing gemcitabine plus carboplatin versus carboplatin alone in advanced ovarian cancer has completed.